Human Papillomavirus Downregulates the Expression of IFITM1 and RIPK3 to Escape from IFNγ- and TNFα-Mediated Antiproliferative Effects and Necroptosis

by Ma, Wenbo, Tummers, Bart, van Esch, Edith M.G., Goedemans, Renske, Melief, Cornelis J.M., Meyers, Craig, Boer, Judith M., van der Burg, Sjoerd H.
Published 2016

The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFκB activation

by Tummers, Bart, Goedemans, Renske, Pelascini, Laetitia P. L., Jordanova, Ekaterina S., van Esch, Edith M. G., Meyers, Craig, Melief, Cornelis J. M., Boer, Judith M., van der Burg, Sjoerd H.
Published 2015

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial

by van Poelgeest, Mariette I E, Welters, Marij J P, van Esch, Edith M G, Stynenbosch, Linda F M, Kerpershoek, Gijs, van Persijn van Meerten, Els L, van den Hende, Muriel, Löwik, Margriet J G, Berends-van der Meer, Dorien M A, Fathers, Lorraine M, Valentijn, A Rob P M, Oostendorp, Jaap, Fleuren, Gert Jan, Melief, Cornelis J M, Kenter, Gemma G, van der Burg, Sjoerd H
Published 2013